Naproxen Sodium
나프록센나트륨
KDMF APIs중추신경계KDMF 등록
품목명 (영문)
Naproxen Sodium
품목명 (한글)
나프록센나트륨
분류
중추신경계
CAS No.
26159-34-2
KDMF 등록번호
20130121-143-I-209-04(6)
제조원
Zhejiang Charioteer Pharmaceutical Co., Ltd.
규격
USP
IUPAC Name
sodium (2S)-2-(6-methoxynaphthalen-2-yl)propanoate
Description
Naproxen is classified as a nonsteroidal anti-inflammatory dug (NSAID) and was initially approved for prescription use in 1976 and then for over-the-counter (OTC) use in 1994. It can effectively manage acute pain as well as pain related to rheumatic diseases, and has a well studied adverse effect profile. Given it's overall tolerability and effectiveness, naproxen can be considered a first line treatment for a variety of clinical situations requiring analgesia. Naproxen is available in both immediate and delayed release formulations, in combination with sumatriptan to treat migraines, and in combination with esomeprazole to lower the risk of developing gastric ulcers
Certificate of Analysis
If you need more information, please contact us.
규격서·시험성적서 등 추가 자료가 필요하시면 문의 시 함께 요청해 주세요. 담당자가 확인 후 회신합니다. (02-579-1056 · ace@acebiopharm.com)